{
    "id": 29560,
    "fullName": "ERBB2 L313I",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "ERBB2 (HER2) L313I lies within the extracellular domain of the Erbb2 (Her2) protein (UniProt.org). L313I has been identified in the scientific literature (PMID: 30301790, PMID: 25975284), but has not been biochemically characterized and therefore, its effect on Erbb2 (Her2) protein function is unknown (PubMed, Sep 2019).",
            "references": [
                {
                    "id": 14478,
                    "pubMedId": 30301790,
                    "title": "Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2).",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30301790"
                },
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 16332,
                    "pubMedId": 25975284,
                    "title": "Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2).",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25975284"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2064,
        "geneSymbol": "ERBB2",
        "terms": [
            "ERBB2",
            "CD340",
            "HER-2",
            "HER-2/neu",
            "HER2",
            "MLN 19",
            "NEU",
            "NGL",
            "TKR1"
        ]
    },
    "variant": "L313I",
    "createDate": "03/14/2019",
    "updateDate": "09/28/2019",
    "referenceTranscriptCoordinates": {
        "id": 178933,
        "transcript": "NM_004448",
        "gDna": "chr17:g.39711963C>A",
        "cDna": "c.937C>A",
        "protein": "p.L313I",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 16397,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, Nerlynx (neratinib) treatment resulted in partial response in 2 of 6 and disease stabilization in 4 of 6 breast cancer patients with ERBB2 (HER2) amplification and an ERBB2 (HER2) mutation, including partial response in a patient harboring ERBB2 (HER2) L313I (PMID: 30301790).",
            "molecularProfile": {
                "id": 31626,
                "profileName": "ERBB2 L313I ERBB2 amp"
            },
            "therapy": {
                "id": 828,
                "therapyName": "Neratinib",
                "synonyms": null
            },
            "indication": {
                "id": 60079,
                "name": "Her2-receptor positive breast cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 14478,
                    "pubMedId": 30301790,
                    "title": "Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2).",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30301790"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31625,
            "profileName": "ERBB2 L313I",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 31626,
            "profileName": "ERBB2 L313I ERBB2 amp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 178934,
            "transcript": "NM_001289937",
            "gDna": "chr17:g.39711963C>A",
            "cDna": "c.937C>A",
            "protein": "p.L313I",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 178933,
            "transcript": "NM_004448",
            "gDna": "chr17:g.39711963C>A",
            "cDna": "c.937C>A",
            "protein": "p.L313I",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}